Previous Article | Next Article 
Journal of Virology, August 2000, p. 7331-7337, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Analysis of Gene Expression in a Human Cell Line
Stably Transduced with Herpesvirus Saimiri
Kersten T.
Hall,
Mathew S.
Giles,
Delyth J.
Goodwin,
Michael
A.
Calderwood,
Ian M.
Carr,
Alex J.
Stevenson,
Alex F.
Markham, and
Adrian
Whitehouse*
Molecular Medicine Unit, University of Leeds,
St. James's University Hospital, Leeds LS9 7TF, United Kingdom
Received 7 February 2000/Accepted 15 May 2000
 |
ABSTRACT |
Herpesvirus saimiri (HVS) is the prototype gamma-2 herpesvirus; it
has significant homology to the human gammaherpesviruses Kaposi's
sarcoma-associated virus and Epstein-Barr virus and the murine
gammaherpesvirus murine herpesvirus 68. HVS causes a persistent asymptomatic infection in its natural host, the squirrel monkey. Both subgroups A and C possess the ability to immortalize common marmoset T lymphocytes to interleukin-2-independent proliferation. However, only subgroup C is capable of transforming human, rabbit, and
rhesus monkey lymphocytes in vitro. In addition, HVS can stably transduce a variety of human cell lines where the virus persists as a nonintegrating circular episome. In this study, we have developed a system in which the HVS DNA is stably maintained as a
nonintegrated circular episome in the human lung carcinoma cell line
A549. Virus production can be reactivated using chemical inducing
agents, including tetradecanoyl phorbol acetate and
n-butyrate, suggesting that the infection in human A549
cells is latent. To analyze virus gene expression in these stably
transduced cells, Northern blot analysis was performed using a series
of probes produced from restriction fragments spanning the entire
coding region of the HVS genome. This demonstrated that an adjacent set
of genes containing open reading frames (ORFs) 71 to 73 are expressed
in this stably transduced cell line. Moreover, these genes are
transcribed as a polycistronic mRNA species produced from a common
promoter upstream of ORF 73. This model may serve as a useful tool in
the further analysis of the role of ORFs 71 to 73 in gamma-2
herpesvirus latency.
 |
INTRODUCTION |
Herpesvirus saimiri (HVS) is the
prototype gamma-2 herpesvirus, or rhadinovirus; it has significant
homology to the human gammaherpesviruses Kaposi's sarcoma-associated
virus (KSHV) and Epstein-Barr virus (EBV) and the murine
gammaherpesvirus murine herpesvirus 68 (MHV-68) (1, 39, 43,
53). HVS was originally isolated from its natural host, the
squirrel monkey (Saimiri sciureus), in which it causes a
persistent asymptomatic infection. However, HVS infection of other New
World primates results in acute T-cell lymphoma within a few weeks
(16). Both subgroups A and C possess the ability to
immortalize common marmoset T lymphocytes to interleukin-2-independent proliferation (10, 49). However, only subgroup C is capable of transforming human, rabbit, and rhesus monkey lymphocytes in vitro
(3, 5-7).
Analysis of the left end of the unique L-DNA of the viral genome of
subgroups A and C has revealed variable open reading frames (ORFs)
(6, 21, 24), which are essential for T-cell transformation (12). HVS subgroup A contains a single ORF, STP-A (saimiri
transforming protein A), whereas subgroup C contains two genes at this
position, STP-C, a divergent form of the STP oncogene, and Tip (which
encodes tyrosine kinase-interacting protein), which interacts with the tyrosine kinase Lck (4, 25, 37, 57). STP-A interacts with a
Src kinase, whereas STP-C associates with cellular Ras (23).
Immortalized T cells harbor the viral genome as a persisting high-copy-number nonintegrating episome without production of virus
particles (5, 26, 55). Initial analysis of viral gene
expression in these cells using Northern blotting suggested that viral
gene expression was confined to the transforming genes (14,
15). However, the use of either STP-C or Tip deletion mutants
demonstrated that these genes were essential for transformation in cell
culture but dispensable for replication or long-term episomal persistence (12).
The HVS genome encodes a number of cellular homologues whose products
may play a role in transformation, immune evasion and long-term
persistence of the viral episome. These include U RNA homologues,
antiapoptotic proteins (ORF16/vBcl2 and ORF71/vFLIP), a cyclin D
homologue (ORF72/vCyclin), complement control inhibitory proteins
(ORF4/CCPH and ORF15/vCD59), nucleotide metabolism enzymes (ORF2/DHFR and ORF70/TS), a viral superantigen (ORF14/vSag),
and cytokine homologues (ORF13/vIL-17 and ORF74/vGCR)
(1). Recent analysis of immortalized T cells by
subtractive hybridization demonstrated that immediate-early
IE14/vSag transcripts were found in abundance (31).
IE14/vSag encodes a 50-kDa secreted glycoprotein which binds to major
histocompatibility complex class II molecules and stimulates T-cell
proliferation (58). Further analysis of the role of
ORF14/vSag by using deletion mutants demonstrated that ORF14/vSag is
dispensable for virus replication but that its role in transformation,
persistence, and pathogenicity is variable depending on the cell type
(13, 32).
Interestingly, HVS also has the ability to infect a variety of human
cell lines, including hematopoietic lineage, myeloid, fibroblast,
and carcinoma-derived cells (19, 46, 47). Although different
levels of virus production have been observed in these cell lines, the
virus generally persists as a nonintegrating circular episome. Analysis
of the HVS genome has identified a cis-acting element which
is required for viral episomal maintenance (34). However, no
protein homologous to the EBV EBNA 1, which enables the EBV genome to
be maintained as a stable episome in latently infected cells (29,
38, 42, 48), has been identified. Recent analysis of primary
effusion lymphoma (PEL) cells harboring latent KSHV episomes
demonstrated that the latency-associated nuclear antigen (LANA) encoded
by ORF 73 colocalized with KSHV DNA. In addition, LANA was necessary
and sufficient for the persistence of episomes containing KSHV DNA,
suggesting that it tethers KSHV DNA to chromosomes during mitosis,
enabling the efficient segregation of KSHV episomes to progeny cells
(2). Moreover, LANA associates with histone HI in
KSHV-infected BCBL cells, suggesting that the tether mechanism by which
episomes are linked to host chromatin occurs via host chromosomal
proteins (2, 8).
These results prompted us to investigate which genes are transcribed in
a nontransformed, stably transduced human cell line where the virus
persists as a nonintegrated episome. In this report, we describe a
system in which HVS DNA is stably maintained as a nonintegrated
circular episome in the human lung carcinoma cell line A549. We show
that virus production can be reactivated using chemical inducing
agents, suggesting that the infection in human A549 cells is truly
latent. Northern blot analysis demonstrated that an adjacent set of
genes containing ORFs 71 to 73 are expressed in this stably transduced
cell line. Moreover, these genes are transcribed from a polycistronic
mRNA species produced from a common promoter upstream of ORF 73.
 |
MATERIALS AND METHODS |
Viruses, cell culture, and transfections.
HVS (strain A11)
and HVS-GFP (56) were propagated in owl monkey kidney (OMK)
cells maintained in Dulbecco's modified Eagle's medium (Life
Technologies) supplemented with 10% fetal calf serum (FCS).
HVS-transformed T cells from cottontop tamarin monkeys, B133 cells
(20, 30), were propagated in RPMI 1640 medium (Life Technologies) supplemented with 10% FCS and interleukin-2 (20 U/ml).
To generate an A549 cell line stably transduced with HVS, 106 A549 cells were infected with HVS-GFP at a multiplicity
of infection (MOI) of 1 and cultured in Dulbecco's modified Eagle's
medium-10% FCS in the presence of 600 µg of Geneticin (Life
Technologies) per ml. Plasmids used in the transfections were prepared
using Qiagen plasmid kits as specified by the manufacturer. Cos-7 cells were seeded at 5 × 105 cells per 35-mm-diameter petri
dish 24 h prior to transfection. Transfections were performed
using Lipofectamine (Life Technologies) as described by the
manufacturer, with 2-µg portions of the appropriate DNAs.
Gardella gel electrophoresis and Southern blot analysis.
Episomal DNA molecules were detected using the Gardella technique as
previously described (9, 17). Horizontal gels were prepared
in two steps. Initially a 0.75% agarose gel in Tris-borate-EDTA (TBE)
buffer was poured. Once it had solidified, 5 cm of the gel was removed
and replaced with 0.8% agarose containing 2% sodium dodecyl sulfate
and 1 mg of self-digested pronase (Sigma) per ml. Control and HVS
stably transduced A549 cells (106) were resuspended in
sample buffer (15% Ficoll, 0.01% bromophenol blue) and
electrophoresed at 4°C for 2 h at 40 V and then for 18 h at
160 V. DNA was detected by Southern blot analysis as previously described (44). DNA was hybridized with a
32P-radiolabelled random-primed probe specific for the
KpnE fragment of the HVS genome, using the Megaprime kit
(Amersham) as described by the manufacturer.
Chemical induction and virus recovery assays.
To induce a
lytic replication cycle in the stably HVS-transduced A549 cell line,
cells were incubated in the presence of either 20 ng of tetradecanoyl
phorbol acetate (TPA) (Sigma, Poole, United Kingdom) per ml or 3 mM
n-butyrate (Sigma) for 48 h. After chemical induction,
virus recovery assays were performed. Serial dilutions of the harvested
supernatants were used to infect 106 OMK cells. After
1 h at 37°C, the supernatants were removed and replaced with
medium supplemented with 2% FCS and 0.45% (wt/vol) high-viscosity
carboxymethyl cellulose (Sigma). The mixtures were transferred to
dishes and incubated at 37°C for 5 to 7 days. The infected cells were
subsequently fixed in Formol saline solution (0.85% [wt/vol] NaCl,
10% [vol/vol] formaldehyde) and stained with 0.1% (wt/vol) gentian
violet, and plaques were counted.
Total-RNA extraction.
Total RNA was extracted from HVS
stably transduced A549 cells and OMK cells infected with HVS (strain
A11) at a MOI of 1, at various times postinfection. The cells were
lysed using Trizol reagent (Life Technologies). Chloroform (0.2 ml) was
then added, and the solution was vortex mixed for 20 s and stored
at 20°C for 15 min. Samples were centrifuged for 15 min at 4°C, and
the aqueous phase containing nucleic acids was precipitated using 0.5 ml of isopropanol. The pellet was then washed with 70% ethanol, resuspended in 50 µl of water, and stored at
70°C.
Northern blot analysis.
Northern blot analysis was performed
essentially as described by Sambrook et al. (44). Total RNA
was isolated from HVS stably transduced A549 cells or HVS-infected OMK
cells and separated by electrophoresis on a 1% denaturing formaldehyde
agarose gel. The RNA was transferred to Hybond-N membranes and
hybridized with 32P-labeled random primed probes. Probes
specific for ORFs 71 to 73 were amplified by PCR using the following
primer pairs: ORF71F (5'-CGC GGA TCC GGC AAG GTC ACT TCG CCC TAT CTG)
plus ORF71R (5'-CCG GAA TTC CTG TGT TAC ACA TAA CAG ACT), ORF72F
(5'-CGC GGA TCC GCT GCA ATG GCA GAT TCA CC) plus ORF72R (5'-CCG GAA TTC
GGT CTG CAG TTA GTG TTG TCA G-3), ORF73F (5'-ACG CGT CGA CCC ATC TAT
AAT TGC AAC AAA CAC C) plus ORF73R (5'-CCC AAG CTT CAC ATA TAT GAA TGC TAG TGC AC), ORF74F (5'-GCT GGG TAT CTG CTA) plus ORF74R (5'-CCA ATA
CAC TAT AGC), and ORF75F (5'-GAA CAT ATG CCA GCT ACA) plus ORF75R
(5'-GTC TCT GGA TCT TCA AGC). The PCR (1 cycle of 5 min at 95°C; 30 cycles of 1 min at 95°C, 1 min at 55°C, and 2 min at 72°C; 1 cycle of 10 min at 72°C) was performed using 2 U of Klentaq (Clontech).
Rapid amplification of cDNA ends (RACE).
First-strand cDNA
was reverse transcribed using Superscript II reverse transcriptase
(Life Technologies) and either an oligo(dT) primer or gene-specific
antisense primers: for ORF 71, 5'-GTG TTT CTA ATT GTG GCT; for ORF 72, 5'-CAC AGA TAT CTG TCT AAG; and for ORF 73, 5'-GTC ATC GTC GCC TTG AGG.
The 5' ends of the ORF 71 to 73 genes were located using the Clontech
Marathon cDNA amplification kit as specified by the manufacturer.
5'-cDNA was amplified using the nested primers ORF 71 (5'-AAG AGG TTC
AGT AAT AGT), ORF 72 (5'-AGC AGA TGC ATC CAG GTA), and ORF 73 (5'-GCA
CAT GAC ACT TAC ATT). The amplified cDNAs were cycle sequenced using
the fmol DNA-sequencing system (Promega).
Primer extension analysis.
Primer extension was performed
essentially as described by Sambrook et al. (44). First, a
21-bp oligonucleotide primer (5'-CGT CTT CTC TTG CGA GGA CTT ACA)
homologous to the ORF 73 coding region was radiolabeled using
[
-32P]ATP. Then 3 µg of RNA was mixed with 300 ng of
the radiolabeled primer. The samples were boiled for 5 min and
snap-chilled on ice. To the reaction mixtures were added 1 mM (each)
dATP, dTTP, dCTP, and dGTP; buffer (final concentrations, 50 mM KCl, 10 mM Tris-HCl [pH 8.3], and 1.5 mM MgCl2); and 1 µl of
Superscript II reverse transcriptase (Life Technologies) in a final
volume of 20 µl. The reaction was performed at 42°C for 60 min, and
primer extension products were resolved on a 6% acrylamide-7 M urea
gel. After electrophoresis, the gel was dried and bands were visualized by exposure to X-ray film.
Plasmid constructs.
The 5' ORF 73 promoter deletion series
was produced by a PCR-based method using a series of forward primers,
1 (5'-AAA CTG CAG CCC AGA GAG CTG GAC ACT),
2 (5'-AAA CTG CAG CCA
TGC AGC CAT GCG CTG),
3 (5'-AAA CTG CAG CAC CAT CAC ATG AGG AAG),
4 (5'-AAA CTG CAG CAC ATA TAT GAA TGC TAG),
5 (5'-AAA CTG CAG GTG
GCT ACA CAG TA), and
6 (5'-AAA CTG CAG CAG TCA TAA TGT GAC C), and a reverse primer (5'-CGC GGA TCC CCA TCT ATA ATT GCA ACA AAC). These oligonucleotides incorporated PstI or SalI
restriction sites for convenient cloning of the PCR products. Each
fragment was inserted into the eukaryotic chloramphenicol
acetyltransferase (CAT) reporter vector, pCATBasic (Promega), to derive
p73
1-5.
CAT assay.
Cell extracts were prepared 48 h after
transfection and incubated with [14C]chloramphenicol in
the presence of acetyl coenzyme A as described previously
(18). The percent acetylation of chloramphenicol was
quantified by scintillation counting (Packard) of appropriate regions
of the thin-layer chromatography plate.
 |
RESULTS |
Production of the HVS stably transduced A549 cell line.
We
have previously constructed a recombinant HVS, HVS-GFP, expressing the
green fluorescent protein (GFP) and the neomycin resistance genes under
the control of the immediate-early cytomegalovirus and simian virus 40 promoters, respectively (56). Analysis of this virus has
demonstrated infection of a wide variety of human cell lines (47,
56). In addition, these cell lines are able to support episomal
persistence of viral genomes, in agreement with previous observations
in human hematopoietic cells and epithelial cells (19, 46).
To generate a lung carcinoma A549 cell line which contained HVS as a
nonintegrated circular episome, 106 A549 cells were
infected with HVS-GFP and cultured in the presence of Geneticin. After
2 weeks, only cells which had been successfully transduced remained
viable, with 100% exhibiting the GFP phenotype when analyzed by
fluorescence microscopy (Fig. 1a). The
cells continued to grow and express the transgene in the presence of selection for over 12 months, suggesting that the infection in this
cell type is highly stable. To verify the existence of virus genomes in
a circular episomal form, untransduced and HVS stably transduced cells
were analyzed by Gardella gel electrophoresis and Southern blot
analysis as previously described (9, 17). An HVS-transformed
T-cell line from cottontop tamarin monkeys, which contains HVS as a
circular nonintegrated episome, was also analyzed as a suitable
control. Results show an episomal band clearly visible in the stably
transduced A549 and transformed cells (Fig. 1b), demonstrating that HVS
is present in a nonintegrated circular form in these A549 cells.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 1.
(a) Production of HVS stably transduced A549 cell line.
A549 cells were infected with HVS-GFP at a MOI of 1 and cultured in the
presence of Geneticin. After 2 weeks, only cells which had been
successfully transduced remained viable, with 100% exhibiting the GFP
phenotype when analyzed by fluorescence microscopy. (b) Gardella gel
and Southern blot analysis of A549 cells (lane 1), HVS stably
transduced A549 cells (lane 2), and HVS-transformed B133 T cells (lane
3). Episomal and linear DNAs were separated by electrophoresis,
transferred to nitrocellulose, and hybridized with a radiolabeled
32P-labeled random-primed probe specific for the
KpnE fragment of the HVS genome.
|
|
Virus production can be reactivated in HVS stably transduced A549
cells.
To determine if HVS episomes were maintained in a latent
state in the stably transduced A549 cells, reactivation of virus production was attempted. To induce a lytic replication cycle, stably
transduced A549 cells were incubated in the presence of either 20 ng of
TPA per ml or 3 mM n-butyrate for 48 h. After chemical
induction, virus recovery assays were performed. Serial dilutions of
the control uninduced and induced harvested supernatants were used to
infect 106 OMK cells, and plaque assays were performed. A
significant increase in PFU was observed from supernatants taken from
the chemically induced cell lines (Fig.
2). A very low level of virus production was observed in the uninduced cell line, suggesting that a small amount
of spontaneous replication does occur in the stably transduced A549
cell line (Fig. 2). However, the induction experiment does suggest that
in the stably transduced A549 cells, HVS is maintained as a latent
nonintegrated circular episome.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 2.
A lytic replication cycle can be induced from the HVS
stably transduced A549 cell line. HVS-infected A549 cells were
incubated in the presence of either no addition (lane 1), 20 ng of TPA
per ml (lane 2), or 3 mM n-butyrate (lane 3) for 48 h.
After chemical induction, virus recovery assays were performed. The
numbers of plaques formed are shown in graphical format: the variations
between three replicate assays are indicated.
|
|
Identification of gene expression in HVS stably transduced A549
cells.
To identify which genes were expressed when the virus is
maintained as a nonintegrated circular episome in stably transduced A549 cells, Northern blot analysis was performed. Total RNA was extracted from the HVS-GFP stably transduced A549 cell line. As controls, total RNA was extracted from lytic infections of OMK cells at
16 and 24 h postinfection and from uninfected A549 cells. Total
RNA was separated by gel electrophoresis on a 1% denaturing formaldehyde-agarose gel, transferred to a nylon membrane, and hybridized with radiolabeled probes specific for a series of
EcoRI or KpnI fragments spanning the entire L-DNA
region of HVS (strain A11) (33).
Northern blot analysis using RNA harvested from a lytic infection
showed strong hybridization with all the HVS genomic
restriction
fragments, indicating a high level of global gene
expression in
the lytic replication cycle (data not shown). However,
transcription
during the latent infection of A549 cells was limited to
genes
within the
KpnE restriction fragment. Two transcripts
approximately
2 and 4 kb in length were identified in the stably
transduced
A549 cells. Although very weak, transcripts were faintly
observed
using probes specific for the highly expressed lytic gene ORF
57 in the latently infected samples (Fig.
3a). We believe that
this may be due to a
very low level of spontaneous lytic replication
in a subpopulation of
the A549 cells. These results suggest that
the HVS genes expressed when
the virus is maintained as a nonintegrated
circular episome in the
stably transduced A549 cell line are confined
to the
KpnE
fragment, which contains ORFs 71 to 75.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 3.
(a) Transcription mapping of the HVS genome in latently
infected A549 cells. Total RNA was extracted from A549 cells (lane 1),
HVS-stably transduced A549 cells (lane 2), OMK cells (lane 3),
16-h-infected OMK cells (lane 4), and 24-h-infected OMK cells (lane 5)
and then separated by gel electrophoresis on a 1% denaturing
formaldehyde-agarose gel. The RNA was transferred to Hybond-N membranes
and hybridized with radiolabeled probes specific for EcoJ
(i) and KpnE (ii). (b) Total RNA was extracted from A549
cells (lane 1) and HVS-stably transduced A549 cells (lane 2) and
separated by gel electrophoresis on a 1% denaturing
formaldehyde-agarose gel. The RNA was transferred to Hybond-N membranes
and hybridized with radiolabeled probes specific for ORF 71 (i), ORF 72 (ii), and ORF 73 (iii).
|
|
ORFs 71 to 73 are expressed in A549 cells stably transduced with
recombinant HVS.
To further ascertain the pattern of gene
expression observed in the stably transduced A549 cells, Northern blot
analysis was repeated, with the same membrane, using probes specific
for ORFs 71 to 75. The results are shown in Fig. 3b. Hybridization with a probe specific for ORF 71 detected only a single transcript of
approximately 2 kb in the stably transduced A549 cells. The probe
specific for ORF 73 detected the 2- and 4.4-kb transcripts, and a probe
specific for ORF 72 detected three transcripts of 2, 4.4, and 1 kb. No
signals were observed with probes specific for ORF 74 or 75 (data not
shown). Therefore, gene expression which could be identified using
Northern blot analysis was limited to ORFs 71 to 73 when HVS was
maintained as a nonintegrated circular episome in the stably transduced
A549 cell line.
Mapping the transcripts of ORFs 71 to 73.
To characterize the
multiple transcripts identified by Northern blot analysis, 5' and 3'
RACE was performed using an oligo(dT) and gene-specific primers for
ORFs 71 to 73. Analysis of the resulting PCR products revealed the
transcription initiation start site was the same for ORFs 71, 72, and
73, situated 24 bp upstream of the ORF 73 initiation codon, at bp
107257 of the published sequence (1) (Fig.
4). Sequencing of the PCR products
demonstrated that these transcripts were produced from a polycistronic
mRNA species comprising the 4.4-kb transcript identified by the
Northern blot analysis. In addition, the polycistronc mRNA species can be spliced, removing a single intron of 1,290 bp with a splice donor
site at bp 107250 and an acceptor site at bp 105966 of the published
sequence (1), to yield the 2-kb bicistronic mRNA containing
ORFs 71 and 72 (Fig. 4). In addition, analysis demonstrated both
transcripts terminated 30 bp downstream of a consensus AAUAAA polyadenylation signal at bp 104395 of the published sequence, 294 bp
downstream of the ORF 71 termination codon. This suggests that both
transcripts are processed at this consensus polyadenylation signal.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 4.
Schematic representation of the genomic
organization of the ORF 71 to 73 region of HVS based on 5' and 3' RACE
and primer extension analysis. The numbers indicate nucleotide
positions based on the published sequence (1).
|
|
To confirm the ORF 73 transcription initiation site identified by 5'
RACE, primer extension analysis was also performed. Total
RNA was
isolated from untransduced A549 cells and HVS stably transduced
cells
and hybridized to a
32P-labeled primer homologous to the
ORF 73 coding region. Primer
extension was then performed, and the
results are shown in Fig.
5. A primer
extension product of 133 bp was observed using RNA
harvested from the
HVS stably transduced cell line but not from
the control A549 cells,
mapping the transcription start site of
ORF 73 to bp 107257 of the
published sequence (
1), confirming
the data obtained in the
above 5'-RACE experiment.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 5.
Primer extension analysis of the ORF 73 transcription
initiation start site. Total RNA was isolated from A549 cells (lane 1)
or HVS-infected A549 cells (lane 2) and hybridized to a
32P-labeled oligomer homologous to the ORF 73 coding
region. Primer extension was performed, and the primer extension
products were run on a 6% acrylamide-7 M urea gel and visualized by
exposure to X-ray film.
|
|
Analysis of the ORF 71 to 73 regulatory region.
To determine
which region upstream of the transcription initiation site contains a
functional promoter from which the polycistronic mRNA transcript is
produced, a series of deletion constructs from the putative promoter
region were cloned upstream of a CAT reporter gene in pCAT-Basic (Fig.
6a). Each promoter construct was
assayed for activity in transiently transfected Cos-7 cells. These were used due to the low transfection efficiency of the stably transduced A549 cells. Transfection efficiency was normalized using a
control plasmid, pCMV
(Clontech), expressing
-galactosidase. The
results of three independent experiments are shown in Fig. 6b. A
1,999-bp fragment containing the sequence from bp 107233 to 109232 of
the published sequence (1) resulted in 15% CAT activity.
Similar results were observed using truncated promoter constructs, up to bp 107562. This suggests that the minimal functional promoter was
contained within the sequence 329 bp upstream of the putative initiation site, i.e., bp 107233 to 107562 of the published sequence (1). To identify potential transcription factor binding
sites within this putative ORF 73 promoter, MatInspector v2.2 was
utilized (40). The putative promoter sequence reveals the
presence of a TATA box and two potential Oct-1 binding sites (Fig. 6c).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 6.
(a) Diagrammatic representation of the deletion series
of the ORF 73 promoter. A series of 5' mutants were constructed by PCR
amplification and ligated into pCAT-Basic. (b) Cos-7 cells were
cotransfected with 2 µg of p73 1-6 in the presence of a
transfection control plasmid, pCMV . Cells were harvested at 48 h posttransfection, and the cell extracts were assayed for CAT
activity. Percentages of acetylation were calculated by scintillation
counting of the appropriate regions of the chromatography plate and are
shown in graphical format: the variations among three replicate assays
are indicated. (c) Potential transcription factor binding sites within
the ORF 73 promoter. The putative transcription start site and
transcription factor binding sites are highlighted.
|
|
 |
DISCUSSION |
In this study, we have investigated viral gene expression in a
stably transduced A549 cell line, where HVS persists as a nonintegrated episome, albeit under selection. We have demonstrated that virus production can be reactivated using both TPA and butyrate, suggesting that the virus is maintained in a latent state. Analysis of gene expression by Northern blot analysis, using RNA extracted from these
stably transduced cells, has demonstrated that three genes are
expressed at high levels, ORFs 71 to 73. Moreover, these genes are
transcribed from a polycistronic mRNA species produced from a common
promoter upstream of ORF 73.
These results are different from the gene expression observed in
HVS-immortalized T cells. Northern blotting and subtractive hybridization techniques have demonstrated that the transforming STP
and Tip genes and the immediate-early IE14/vSag genes are expressed
(14, 15, 31). Although we have not detected the expression
of other virus genes using Northern blot analysis, it cannot be
excluded that a more sensitive method may identify additional virus
gene expression. However, it is interesting that viral gene expression
observed in the HVS stably transduced A549 cell line has similarities
to gene expression during latent infections with other
gammaherpesviruses, particularly KSHV (11, 29, 45, 50, 54).
A recent survey of KSHV gene transcription in the PEL cell line showed
that a region spanning ORFs 71 to 73 is expressed and that separate
mRNAs for ORF 73 and ORF 72 are generated from a common
latency-specific promoter (11). This result is further
supported by the work of Sarid et al. (45) and Talbot et al.
(50), who detected two transcripts of approximately 6.0 and
2.0 kb in BC-1 cells and PEL cell lines, respectively. The larger
transcript encodes the ORF 73, ORF 72, and ORF K13 products, while the
smaller transcript encodes only the ORF 72 and ORF K13 products but not
the ORF 73 product. Although similar expression is observed in the HVS
stably transduced A549 cells, it must be noted that the HVS transcripts
are produced from a promoter that does not correspond precisely to the
promoters mapped expressing the latent KSHV genes (11, 45).
At present we are determining if a functional promoter is present in
the corresponding position in the HVS genome.
Previous analysis of the HVS ORF 71 and ORF 72 genes has shown that
they encode a FLICE antiapoptosis inhibitory protein (vFLIP) and a
homologue of the cellular type D cyclin, respectively (22, 52). V-cyclin associates with cdk6, and this complex is capable of directing phosphorylation of the retinoblastoma protein
(22). Expression of these two gene products in the latent
stably transduced A549 cells may serve to protect virus-infected cells
from death receptor-induced apoptosis and drive host cell transit
through the pRB-controlled G1 checkpoint, enabling viral
DNA synthesis to occur. At present, the role of the ORF 73 gene product
has yet to be conclusively determined.
ORF 73 is also transcribed in KSHV and MHV-68 latent infections
(11, 45, 50, 54). Sera from KSHV-infected individuals react
in immunofluorescence studies with LANA in latently infected BCBL cell
lines, giving a characteristic speckled immunofluorescence pattern. In
Western blot analysis of nuclear extracts from the BCBL cell line BC-1,
patient sera have been shown to react with a 222- and 234-kDa doublet
band, termed the latent nuclear antigen (LNA). It has been shown that
LNA is encoded by ORF 73 of KSHV and that antibodies to this protein
produce the speckled nuclear immunofluorescence pattern characteristic
of LANA. This suggests that the ORF 73 LNA product is at least a
component of LANA (27, 28, 41).
It is interesting that ORF 73 is contained in a region of the HVS
genome which is poorly conserved among gammaherpesviruses. Equine
herpesvirus 2, for example, lacks an ORF 73 homologue (51), and the ORF 73 homologues of bovine herpesvirus 4 and MHV-68 do not
contain the internal acidic repeat region found in the ORF 73 of KSHV
and HVS (36, 53). A similar acidic domain is found in the
latent EBV EBNA-1 protein, which inhibits recognition of this antigen
by cytotoxic T lymphocytes (35). In addition, the speckled
nuclear staining pattern of ORF 73-encoded LANA is similar to that
observed with EBNA-2 and EBNA-LP, which are the earliest proteins
expressed in B lymphocytes newly infected with EBV and are essential
for B-lymphocyte transformation (reviewed in reference 29). Furthermore, LANA colocalizes with KSHV DNA in
dots in interphase nuclei and along mitotic chromosomes, and LANA is
required for the persistence of episomes containing a specific KSHV
cis-acting region. Moreover, LANA associates with histone HI
in KSHV-infected BCBL cells, suggesting that LANA tethers KSHV DNA to
chromosomes via host chromosomal proteins during mitosis, allowing the
segregation of the KSHV episomes to progeny cells (2, 8).
Whether HVS ORF 73 plays a role in host cell transformation, episomal
persistence or cell cycle regulation is unknown and further
investigation of the role of the ORF 73 gene product in HVS episomal
maintenance is required.
In conclusion, we have developed an in vitro model which may be
valuable in the study of genes involved in episomal maintenance of
gamma-2 herpesviruses, based on the nontransformed lung carcinoma cell
line A549. The stably transduced cell line contains HVS as a
nonintegrated episome which is efficiently segregated to progeny cells.
Analysis of viral gene expression in this model has shown that three
genes, ORFs 71 to 73, are expressed as a polycistronic mRNA from a
common promoter upstream of ORF 73. This model may serve as a useful
tool in the further analysis of the role of ORFs 71 to 73 in gamma-2
herpesvirus latency. In particular, due to the lack of a permissive
cell culture system for KSHV and the fact that it is possible to
produce recombinant HVS mutants, we believe that this HVS model may
serve as a useful tool in the further analysis of the role of ORFs 71 to 73 in KSHV latency.
 |
ACKNOWLEDGMENTS |
We thank Helmut Fickenscher for providing the library of HVS-11
genomic clones and the transformed B133 cell line and for helpful advice.
This work was supported in parts by grants from Medical Research
Council, Yorkshire Cancer Research, Candlelighter's Trust, and the
Wellcome Trust. A.W. and D.J.G. are the recipients of an MRC fellowship
and Ph.D. studentship, respectively. M.S.G. is a Wellcome Trust Entry
Level Clinical Research Fellow.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Medicine Unit, University of Leeds, St. James's University Hospital,
Leeds LS9 7TF, United Kingdom. Phone: 44-113 2066328. Fax: 44-113 2444475. E-mail:
A.Whitehouse{at}leeds.ac.uk.
 |
REFERENCES |
| 1.
|
Albrecht, J.-C.,
J. Nicholas,
D. Biller,
K. R. Cameron,
B. Biesinger,
C. Newman,
S. Wittmann,
M. A. Craxton,
H. Coleman,
B. Fleckenstein, and R. W. Honess.
1992.
Primary structure of the herpesvirus saimiri genome.
J. Virol.
66:5047-5058[Abstract/Free Full Text].
|
| 2.
|
Ballestas, M. E.,
P. A. Chatis, and K. M. Kaye.
1999.
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen.
Science
284:641-644[Abstract/Free Full Text].
|
| 3.
|
Behrend, K.,
J. Jung,
T. Boyle,
M. DiMaio,
S. Mungal,
R. Desrosiers, and K. Lyerly.
1993.
Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytes.
J. Virol.
67:6317-6321[Abstract/Free Full Text].
|
| 4.
|
Biesinger, B.,
A. Tsygankov,
H. Fickenscher,
F. Emmrich,
B. Fleckenstein,
J. Bolen, and B. Broker.
1995.
The product of the herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells.
J. Biol. Chem.
270:4729-4734[Abstract/Free Full Text].
|
| 5.
|
Biesinger, B.,
I. Muller-Fleckenstein,
B. Simmer,
G. Lang,
S. Wittmann,
E. Platzer,
R. C. Desrosiers, and B. Fleckenstein.
1992.
Stable growth transformation of human T lymphocytes by herpesvirus saimiri.
Proc. Natl. Acad. Sci. USA
89:3116-3119[Abstract/Free Full Text].
|
| 6.
|
Biesinger, B.,
J. Trimble,
R. C. Desrosiers, and B. Fleckenstein.
1990.
The divergence between two oncogenic herpesvirus saimiri strains in a genomic region related to the transforming phenotype.
Virology
176:505-514[CrossRef][Medline].
|
| 7.
|
Broker, B.,
A. Tsygankov,
I. Muller-Fleckenstein,
A. Guse,
N. Chitaev,
B. Biesinger,
B. Fleckenstein, and F. Emmrich.
1993.
Immortalisation of human T cell clones by herpesvirus saimiri. Signal transduction analysis reveals functional CD3, CD4 and IL-2 receptors.
J. Immunol.
51:1184-1192.
|
| 8.
|
Cotter, M. A., and E. S. Robertson.
1999.
The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma.
Virology
264:254-264[CrossRef][Medline].
|
| 9.
|
Decker, L. L.,
L. D. Klaman, and D. A. Thorley-Lawson.
1996.
Detection of the latent form of Epstein-Barr virus DNA in the peripheral blood of healthy individuals.
J. Virol.
70:3286-3289[Abstract].
|
| 10.
|
Desrosiers, R. C.,
D. Silva,
L. Waldron, and N. Letvin.
1986.
Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization.
J. Virol.
57:701-705[Abstract/Free Full Text].
|
| 11.
|
Dittmer, D.,
M. Lagunoff,
R. Renne,
K. Staskus,
A. Haase, and D. Ganem.
1998.
A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.
J. Virol.
72:8309-8315[Abstract/Free Full Text].
|
| 12.
|
Duboise, S. M.,
J. Guo,
S. Czajak,
R. C. Desrosiers, and J. U. Jung.
1998.
STP and Tip are essential for herpesvirus saimiri oncogenicity.
J. Virol.
72:1308-1313[Abstract/Free Full Text].
|
| 13.
|
Duboise, S. M.,
J. Guo,
S. Czajak,
H. Lee,
R. Veazey,
R. C. Desrosiers, and J. U. Jung.
1998.
A role for herpesvirus saimiri orf14 in transformation and persistent infection.
J. Virol.
72:6770-6776[Abstract/Free Full Text].
|
| 14.
|
Fickenscher, H.,
B. Biesinger,
A. Knappe,
S. Wittman, and B. Fleckenstein.
1996.
Regulation of the herpesvirus saimiri oncogene stpC, similar to that of T-cell activation genes, in growth-transformed human T lymphocytes.
J. Virol.
70:6012-6019[Abstract].
|
| 15.
|
Fickenscher, H.,
C. Bokel,
A. Knappe,
B. Biesinger,
E. Meinl,
B. Fleischer,
B. Fleckenstein, and B. M. Broker.
1997.
Functional phenotype of transformed human alpha/beta and gamma/delta T cells determined by different subgroup C strains of herpesvirus saimiri.
J. Virol.
71:2552-2262.
|
| 16.
| Fleckenstein, B., and R. C. Desrosiers.
Herpesvirus saimiri and herpesvirus ateles, p. 253-332. In
B. Roizman (ed.), The herpesviruses, vol. 1. Plenum Press, New York,
N.Y.
|
| 17.
|
Gardella, T.,
P. Medveczky,
T. Sairenji, and C. Mulder.
1984.
Detection of circular and linear herpesvirus DNA molecules in mammalian cells by gel electrophoresis.
J. Virol.
50:248-254[Abstract/Free Full Text].
|
| 18.
|
Gorman, C. M.,
L. F. Moffat, and B. H. Howard.
1982.
Recombinant genomes which express chloramphenicol acetyl-transferase in mammalian cells.
Mol. Cell. Biol.
2:1044-1051[Abstract/Free Full Text].
|
| 19.
|
Grassmann, R., and B. Fleckenstein.
1989.
Selectable recombinant herpesvirus saimiri is capable of persisting in a human cell line.
J. Virol.
63:1818-1821[Abstract/Free Full Text].
|
| 20.
|
Hiller, C.,
S. Wittmann,
S. Slavin, and H. Fickenscher.
2000.
Functional long-term thymidine kinase suicide gene expression in human T cells using a herpesvirus saimiri vector.
Gene Ther.
7:664-674[CrossRef][Medline].
|
| 21.
|
Jung, J. U.,
J. J. Trimble,
N. W. King,
B. Biesinger,
B. W. Fleckenstein, and R. C. Desrosiers.
1991.
Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri.
Proc. Natl. Acad. Sci. USA
88:7051-7055[Abstract/Free Full Text].
|
| 22.
|
Jung, J. U.,
M. Stager, and R. C. Desrosiers.
1994.
Virus-encoded cyclin.
Mol. Cell. Biol.
14:7235-7244[Abstract/Free Full Text].
|
| 23.
|
Jung, J. U., and R. C. Desrosiers.
1995.
Association of the viral oncoprotein STP-C488 with cellular Ras.
Mol. Cell. Biol.
15:6506-6512[Abstract].
|
| 24.
|
Jung, J. U., and R. C. Desrosiers.
1991.
Identification and characterization of the herpesvirus saimiri oncoprotein, STP-C488.
J. Virol.
65:6953-6960[Abstract/Free Full Text].
|
| 25.
|
Jung, J. U.,
S. Lang,
T. Jun,
T. M. Roberts,
A. Veillette, and R. C. Desrosiers.
1995.
Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri.
J. Virol.
69:7814-7822[Abstract].
|
| 26.
|
Kaschaka-Dierich, C.,
F. J. Werner,
I. Bauer, and B. Fleckenstein.
1982.
Structure of nonintegrated circular herpesvirus saimiri and herpesvirus ateles genomes in tumor cell lines and in vitro-immortalized cells.
J. Virol.
44:295-310[Abstract/Free Full Text].
|
| 27.
|
Kedes, D. H.,
M. Lagunoff,
R. Renne, and D. Ganem.
1997.
Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus.
J. Clin. Investig.
100:2606-2610[Medline].
|
| 28.
|
Kellam, P.,
C. Boshoff,
D. Whitby,
S. Matthews,
R. A. Weiss, and S. J. Talbot.
1997.
Identification of a major latent nuclear antigen LNA-1, in the human herpesvirus 8 genome.
J. Hum. Virol.
1:19-29[Medline].
|
| 29.
|
Kieff, E.
1996.
Epstein-Barr virus and its replication, p. 2343-2396.
In
B. N. Fields, D. M. Knipe, P. M. Howley, et al. (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 30.
|
Knappe, A.,
C. Hiller,
H. Niphuis,
F. Fossiez,
M. Thurau,
S. Wittmann,
E. M. Kuhn,
S. Lebecque,
J. Banchereau,
B. Rosenwirth,
B. Fleckenstein,
J. Heeney, and H. Fickenscher.
1998.
The interleukin-17 gene of herpesvirus saimiri.
J. Virol.
72:5797-5801[Abstract/Free Full Text].
|
| 31.
|
Knappe, A.,
C. Hiller,
M. Thurau,
S. Wittman,
H. Hofmann,
B. Fleckenstein, and H. Fickenscher.
1997.
The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells.
J. Virol.
71:9124-9133[Abstract].
|
| 32.
|
Knappe, A.,
M. Thurau,
H. Niphuis,
C. Hiller,
S. Wittman,
E. M. Kuhn,
B. Rosenwirth,
B. Fleckenstein,
J. Heeney, and H. Fickenscher.
1998.
T-cell lymphoma caused by herpesvirus saimiri C488 independently of ie14/vsag, a viral gene with superantigen homology.
J. Virol.
72:3469-3471[Abstract/Free Full Text].
|
| 33.
|
Knust, E.,
S. Schirm,
W. Dietrich,
W. Bodemer,
E. Kolb, and B. Fleckenstein.
1983.
Cloning of herpesvirus saimiri DNA fragments representing the entire L-region of the genome.
Gene
25:281-289[CrossRef][Medline].
|
| 34.
|
Kung, S. H., and P. G. Medveczky.
1996.
Identification of a herpesvirus saimiri cis-acting DNA fragment that permits stable replication of episomes in transformed T cells.
J. Virol.
70:1738-1744[Abstract].
|
| 35.
|
Levitskaya, J.,
M. Coram,
V. Levitsky,
S. Imreh,
P. M. Stigerwald-Mullen,
G. Klein,
M. G. Kurilla, and M. G. Masucci.
1995.
Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.
Nature
375:685-688[CrossRef][Medline].
|
| 36.
|
Lomonte, P.,
M. Bublot,
V. van Santen,
G. M. Keil,
P.-P. Pastoret, and E. Thiry.
1995.
Analysis of bovine herpesvirus 4 genomic regions located outside the conserved gammaherpesvirus gene blocks.
J. Gen. Virol.
76:1835-1841[Abstract/Free Full Text].
|
| 37.
|
Lund, T.,
M. Medveczky,
P. Neame, and P. Medveczky.
1996.
A herpesvirus saimiri membrane protein required for interleukin-2 independence forms a stable complex with p56lck.
J. Virol.
70:600-606[Abstract].
|
| 38.
|
Middleton, T., and B. Sugden.
1994.
Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1.
J. Virol.
68:4067-4071[Abstract/Free Full Text].
|
| 39.
|
Niepel, F.,
J. C. Albrecht, and B. Fleckenstein.
1997.
Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity?
J. Virol.
71:4187-4192[Medline].
|
| 40.
|
Quandt, K.,
K. Frech,
H. Karas,
E. Wingender, and T. Werner.
1995.
MatInd and MatInspector new fast and versatile tools for detection of consensus matches in nucleotide sequence data.
Nucleic Acids Res.
23:4878-4884[Abstract/Free Full Text].
|
| 41.
|
Rainbow, L.,
G. M. Platt,
G. R. Simpson,
R. Sarid,
S.-J. Gao,
H. Stoiber,
C. S. Herrington,
P. S. Moore, and T. F. Schulz.
1997.
The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen.
J. Virol.
71:5915-5921[Abstract].
|
| 42.
|
Reisman, D.,
J. Yates, and B. Sugden.
1985.
A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components.
Mol. Cell. Biol.
5:1822-1832[Abstract/Free Full Text].
|
| 43.
|
Russo, J. J.,
R. A. Bohenzhy,
M. C. Chein,
J. Chen,
M. Yan,
D. Maddalena,
J. P. Parry,
D. Peruzzi,
I. S. Edelman,
Y. Chang, and P. S. Moore.
1996.
Nucleotide sequences of the Kaposi's sarcoma-associated herpesvirus (HHV8).
Proc. Natl. Acad. Sci. USA
93:14862-14867[Abstract/Free Full Text].
|
| 44.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 45.
|
Sarid, R.,
J. S. Wiezorek,
P. S. Moore, and Y. Chang.
1999.
Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter.
J. Virol.
73:1438-1446[Abstract/Free Full Text].
|
| 46.
|
Simmer, B.,
M. Alt,
I. Buckreus,
S. Berthold,
B. Fleckenstein,
E. Platzer, and R. Grassman.
1991.
Persistence of selectable herpesvirus saimiri in various human haematopoietic and epithelial cell lines.
J. Gen. Virol.
72:1953-1958[Abstract/Free Full Text].
|
| 47.
|
Stevenson, A. J.,
M. Cooper,
J. C. Griffiths,
P. G. Gibson,
A. Whitehouse,
E. F. Jones,
S. E. Kinsey,
A. F. Markham, and D. M. Meredith.
1999.
Assessment of herpesvirus saimiri as a potential human gene therapy vector.
J. Med. Virol.
57:269-277[CrossRef][Medline].
|
| 48.
|
Sugden, B.,
K. Marsh, and J. Yates.
1985.
A vector that replicates as a plasmid and can be efficiently selected in B-lymphocytes transformed by Epstein-Barr virus.
Mol. Cell. Biol.
5:410-413[Abstract/Free Full Text].
|
| 49.
|
Szomolanyi, E.,
P. Medvecsky, and C. Mulder.
1987.
In vitro immortalization of marmoset cells with three subgroups of herpesvirus saimiri.
J. Virol.
61:3485-3490[Abstract/Free Full Text].
|
| 50.
|
Talbot, S. J.,
R. A. Weiss,
P. Kellam, and C. Boshoff.
1999.
Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line.
Virology
257:84-94[CrossRef][Medline].
|
| 51.
|
Telford, E. A. R.,
M. S. Watson,
H. C. Aird,
J. Perry, and A. J. Davison.
1995.
The DNA sequence of equine herpesvirus 2.
J. Mol. Biol.
249:520-528[CrossRef][Medline].
|
| 52.
|
Thome, M.,
P. Schneider,
K. Hofmann,
H. Fickenscher,
E. Meinl,
F. Neipel,
C. Mattmann,
K. Burns,
J. L. Bodmer,
M. Schroter,
C. Scaffidi,
P. H. Krammer,
M. E. Peter, and J. Tschopp.
1997.
Viral FLICE-inhibitory protein (FLIPs) prevent apoptosis induced by death receptors.
Nature
386:517-521[CrossRef][Medline].
|
| 53.
|
Virgin, H. W., IV,
P. Latreille,
P. Wamsley,
K. Hallsworth,
K. E. Weck,
A. J. Dal Canto, and S. H. Speck.
1997.
Complete sequence and genomic analysis of murine gammaherpesvirus 68.
J. Virol.
71:5894-5904[Abstract].
|
| 54.
|
Virgin, H. W., IV,
R. M. Presti,
X.-Y. Li,
C. Liu, and S. H. Speck.
1999.
Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice.
J. Virol.
73:2321-2332[Abstract/Free Full Text].
|
| 55.
|
Werner, F.,
G. W. Bornkamm, and B. Fleckenstein.
1977.
Episomal viral DNA in a herpesvirus saimiri-transformed lymphoid cell line.
J. Virol.
22:794-803[Abstract/Free Full Text].
|
| 56.
|
Whitehouse, A., and A. J. Stevenson.
1999.
Gene regulation in herpesvirus saimiri and its implication towards the development of a novel gene therapy vector.
Gene Ther. Mol. Biol.
3:35-44.
|
| 57.
|
Wiese, N.,
A. Tsyganov,
U. Klauenberg,
J. Bolen,
B. Fleischer, and B. Broker.
1996.
Selective activation of T cell kinase p56lck by herpesvirus saimiri protein Tip.
J. Biol. Chem.
271:847-852[Abstract/Free Full Text].
|
| 58.
|
Yao, Z.,
E. Maraskovsky,
M. K. Spriggs,
J. I. Cohen,
R. J. Armitage, and M. R. Alderson.
1996.
Herpesvirus saimiri open reading frame 14, a protein encoded by a T lymphotrophic herpesvirus, binds to MHC class II molecules and stimulates T cell proliferation.
J. Immunol.
56:3260-3266.
|
Journal of Virology, August 2000, p. 7331-7337, Vol. 74, No. 16
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gao, J., Coulson, J. M., Whitehouse, A., Blake, N.
(2009). Reduction in RNA Levels Rather than Retardation of Translation Is Responsible for the Inhibition of Major Histocompatibility Complex Class I Antigen Presentation by the Glutamic Acid-Rich Repeat of Herpesvirus Saimiri Open Reading Frame 73. J. Virol.
83: 273-282
[Abstract]
[Full Text]
-
Griffiths, R., Harrison, S. M., Macnab, S., Whitehouse, A.
(2008). Mapping the minimal regions within the ORF73 protein required for herpesvirus saimiri episomal persistence. J. Gen. Virol.
89: 2843-2850
[Abstract]
[Full Text]
-
Griffiths, R., Whitehouse, A.
(2007). Herpesvirus Saimiri Episomal Persistence Is Maintained via Interaction between Open Reading Frame 73 and the Cellular Chromosome-Associated Protein MeCP2. J. Virol.
81: 4021-4032
[Abstract]
[Full Text]
-
Allen, R. D. III, Dickerson, S., Speck, S. H.
(2006). Identification of Spliced Gammaherpesvirus 68 LANA and v-Cyclin Transcripts and Analysis of Their Expression In Vivo during Latent Infection. J. Virol.
80: 2055-2062
[Abstract]
[Full Text]
-
Wakenshaw, L., Walters, M. S., Whitehouse, A.
(2005). The Herpesvirus Saimiri Replication and Transcription Activator Acts Synergistically with CCAAT Enhancer Binding Protein Alpha To Activate the DNA Polymerase Promoter. J. Virol.
79: 13548-13560
[Abstract]
[Full Text]
-
Calderwood, M., White, R. E., Griffiths, R. A., Whitehouse, A.
(2005). Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence. J. Gen. Virol.
86: 2703-2708
[Abstract]
[Full Text]
-
Gillet, L., Minner, F., Detry, B., Farnir, F., Willems, L., Lambot, M., Thiry, E., Pastoret, P.-P., Schynts, F., Vanderplasschen, A.
(2004). Investigation of the Susceptibility of Human Cell Lines to Bovine Herpesvirus 4 Infection: Demonstration that Human Cells Can Support a Nonpermissive Persistent Infection Which Protects Them against Tumor Necrosis Factor Alpha-Induced Apoptosis. J. Virol.
78: 2336-2347
[Abstract]
[Full Text]
-
Calderwood, M. A., Hall, K. T., Matthews, D. A., Whitehouse, A.
(2004). The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. J. Gen. Virol.
85: 147-153
[Abstract]
[Full Text]
-
White, R. E., Calderwood, M. A., Whitehouse, A.
(2003). Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence. J. Gen. Virol.
84: 3393-3403
[Abstract]
[Full Text]
-
Verma, S. C., Robertson, E. S.
(2003). ORF73 of Herpesvirus Saimiri Strain C488 Tethers the Viral Genome to Metaphase Chromosomes and Binds to cis-Acting DNA Sequences in the Terminal Repeats. J. Virol.
77: 12494-12506
[Abstract]
[Full Text]
-
Schafer, A., Lengenfelder, D., Grillhosl, C., Wieser, C., Fleckenstein, B., Ensser, A.
(2003). The Latency-Associated Nuclear Antigen Homolog of Herpesvirus Saimiri Inhibits Lytic Virus Replication. J. Virol.
77: 5911-5925
[Abstract]
[Full Text]
-
Hall, K. T., Giles, M. S., Calderwood, M. A., Goodwin, D. J., Matthews, D. A., Whitehouse, A.
(2002). The Herpesvirus Saimiri Open Reading Frame 73 Gene Product Interacts with the Cellular Protein p32. J. Virol.
76: 11612-11622
[Abstract]
[Full Text]
-
Coulter, L. J., Reid, H. W.
(2002). Isolation and expression of three open reading frames from ovine herpesvirus-2. J. Gen. Virol.
83: 533-543
[Abstract]
[Full Text]
-
Goodwin, D. J., Walters, M. S., Smith, P. G., Thurau, M., Fickenscher, H., Whitehouse, A.
(2001). Herpesvirus Saimiri Open Reading Frame 50 (Rta) Protein Reactivates the Lytic Replication Cycle in a Persistently Infected A549 Cell Line. J. Virol.
75: 4008-4013
[Abstract]
[Full Text]
-
Hall, K. T., Giles, M. S., Goodwin, D. J., Calderwood, M. A., Markham, A. F., Whitehouse, A.
(2000). Characterization of the herpesvirus saimiri ORF73 gene product. J. Gen. Virol.
81: 2653-2658
[Abstract]
[Full Text]